Combination Chemotherapy in Treating Patients With Bladder Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

490

Participants

Timeline

Start Date

April 2, 1999

Primary Completion Date

August 31, 2001

Study Completion Date

June 15, 2007

Conditions
Bladder CancerUrethral Cancer
Interventions
DRUG

carboplatin

DRUG

cisplatin

DRUG

doxorubicin hydrochloride

DRUG

methotrexate

DRUG

paclitaxel

DRUG

vinblastine sulfate

Trial Locations (13)

10010

Veterans Affairs Medical Center - New York, New York

10016

NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York

30033

Veterans Affairs Medical Center - Atlanta (Decatur), Decatur

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

46202

Indiana University Hospitals, Indianapolis

08822

Hunterdon Regional Cancer Center, Flemington

07601

Hackensack University Medical Center, Hackensack

08332

South Jersey Hospital - Millville, Millville

08060

Fox Chase Cancer Center at Virtua-Memorial Hospital Burlington County, Mount Holly

07701

Riverview Medical Center, Red Bank

07902-0220

Overlook Hospital, Summit

19102-1192

Hahnemann University Hospital, Philadelphia

37232-6838

Vanderbilt Cancer Center, Nashville

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Eastern Cooperative Oncology Group

NETWORK

NCT00003701 - Combination Chemotherapy in Treating Patients With Bladder Cancer | Biotech Hunter | Biotech Hunter